Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

NYSE:CX - New York Stock Exchange, Inc. - US1512908898 - ADR - Currency: USD

6.15  +0.05 (+0.82%)

After market: 6.15 0 (0%)

Fundamental Rating

4

Taking everything into account, CX scores 4 out of 10 in our fundamental rating. CX was compared to 12 industry peers in the Construction Materials industry. There are concerns on the financial health of CX while its profitability can be described as average. CX is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CX was profitable.
In the past year CX had a positive cash flow from operations.
CX had positive earnings in 4 of the past 5 years.
CX had a positive operating cash flow in each of the past 5 years.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CX has a Return On Assets of 4.37%. This is amonst the worse of the industry: CX underperforms 91.67% of its industry peers.
The Return On Equity of CX (9.80%) is worse than 91.67% of its industry peers.
CX's Return On Invested Capital of 8.41% is on the low side compared to the rest of the industry. CX is outperformed by 66.67% of its industry peers.
CX had an Average Return On Invested Capital over the past 3 years of 6.81%. This is significantly below the industry average of 20.02%.
The last Return On Invested Capital (8.41%) for CX is above the 3 year average (6.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.37%
ROE 9.8%
ROIC 8.41%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

CX's Profit Margin of 5.89% is on the low side compared to the rest of the industry. CX is outperformed by 91.67% of its industry peers.
In the last couple of years the Profit Margin of CX has grown nicely.
Looking at the Operating Margin, with a value of 11.14%, CX is doing worse than 83.33% of the companies in the same industry.
In the last couple of years the Operating Margin of CX has grown nicely.
The Gross Margin of CX (33.63%) is better than 75.00% of its industry peers.
In the last couple of years the Gross Margin of CX has remained more or less at the same level.
Industry RankSector Rank
OM 11.14%
PM (TTM) 5.89%
GM 33.63%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

CX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CX has an improved debt to assets ratio.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that CX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.59, CX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CX has a debt to FCF ratio of 11.20. This is a negative value and a sign of low solvency as CX would need 11.20 years to pay back of all of its debts.
The Debt to FCF ratio of CX (11.20) is worse than 83.33% of its industry peers.
A Debt/Equity ratio of 0.51 indicates that CX is somewhat dependend on debt financing.
CX has a Debt to Equity ratio of 0.51. This is comparable to the rest of the industry: CX outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 11.2
Altman-Z 1.59
ROIC/WACC0.66
WACC12.84%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.82 indicates that CX may have some problems paying its short term obligations.
The Current ratio of CX (0.82) is worse than 91.67% of its industry peers.
A Quick Ratio of 0.58 indicates that CX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.58, CX is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.58
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for CX have decreased strongly by -42.46% in the last year.
Measured over the past years, CX shows a very strong growth in Earnings Per Share. The EPS has been growing by 76.58% on average per year.
The Revenue has decreased by -6.83% in the past year.
CX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)-42.46%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%-52.94%
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-11.8%

3.2 Future

The Earnings Per Share is expected to decrease by -18.89% on average over the next years. This is quite bad
The Revenue is expected to grow by 4.14% on average over the next years.
EPS Next Y-64.42%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-2.68%
Revenue Next 2Y0.45%
Revenue Next 3Y1.04%
Revenue Next 5Y4.14%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50B 100B 150B 200B 250B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.99 indicates a rather cheap valuation of CX.
CX's Price/Earnings ratio is rather cheap when compared to the industry. CX is cheaper than 91.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of CX to the average of the S&P500 Index (28.22), we can say CX is valued rather cheaply.
The Price/Forward Earnings ratio is 1.99, which indicates a rather cheap valuation of CX.
Based on the Price/Forward Earnings ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.86, CX is valued rather cheaply.
Industry RankSector Rank
PE 1.99
Fwd PE 1.99
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CX is valued cheaper than 91.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CX is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.92
EV/EBITDA 4.07
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as CX's earnings are expected to decrease with -18.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 40.66%, CX is a good candidate for dividend investing.
CX's Dividend Yield is rather good when compared to the industry average which is at 6.63. CX pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 40.66%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

7.54% of the earnings are spent on dividend by CX. This is a low number and sustainable payout ratio.
DP7.54%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (5/2/2025, 8:04:00 PM)

After market: 6.15 0 (0%)

6.15

+0.05 (+0.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)07-24 2025-07-24
Inst Owners26.76%
Inst Owner Change-0.12%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.92B
Analysts81.33
Price Target5.82 (-5.37%)
Short Float %1.67%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 40.66%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP7.54%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.02067)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-61.81%
Min EPS beat(2)-88.35%
Max EPS beat(2)-35.28%
EPS beat(4)1
Avg EPS beat(4)343.85%
Min EPS beat(4)-88.35%
Max EPS beat(4)1550.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.59%
Min Revenue beat(2)-8.32%
Max Revenue beat(2)-4.86%
Revenue beat(4)0
Avg Revenue beat(4)-5.42%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-2%
Revenue beat(8)1
Avg Revenue beat(8)-3.36%
Revenue beat(12)2
Avg Revenue beat(12)3.78%
Revenue beat(16)2
Avg Revenue beat(16)-9.89%
PT rev (1m)-10.09%
PT rev (3m)-2.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.74%
Revenue NY rev (1m)-2.34%
Revenue NY rev (3m)9.1%
Valuation
Industry RankSector Rank
PE 1.99
Fwd PE 1.99
P/S 0.44
P/FCF 14.92
P/OCF 4.71
P/B 0.73
P/tB 3.17
EV/EBITDA 4.07
EPS(TTM)3.09
EY50.24%
EPS(NY)3.09
Fwd EY50.24%
FCF(TTM)0.41
FCFY6.7%
OCF(TTM)1.31
OCFY21.23%
SpS13.97
BVpS8.39
TBVpS1.94
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 4.37%
ROE 9.8%
ROCE 10.65%
ROIC 8.41%
ROICexc 8.86%
ROICexgc 16.56%
OM 11.14%
PM (TTM) 5.89%
GM 33.63%
FCFM 2.95%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexcg growth 3Y3.59%
ROICexcg growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score7
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 11.2
Debt/EBITDA 1.78
Cap/Depr 103.68%
Cap/Sales 6.4%
Interest Coverage 3.64
Cash Conversion 53.99%
Profit Quality 50.12%
Current Ratio 0.82
Quick Ratio 0.58
Altman-Z 1.59
F-Score7
WACC12.84%
ROIC/WACC0.66
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.46%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%-52.94%
EPS Next Y-64.42%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-11.8%
Revenue Next Year-2.68%
Revenue Next 2Y0.45%
Revenue Next 3Y1.04%
Revenue Next 5Y4.14%
EBIT growth 1Y22.13%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year62.29%
EBIT Next 3Y20.65%
EBIT Next 5YN/A
FCF growth 1Y-39.23%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-12.27%
OCF growth 3Y0.91%
OCF growth 5Y6.96%